Company & Sponsor Intelligence
Radboud University Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting0
Completed2
Countries1
Therapeutic footprint
alzheimersparkinsons
Indexed studies
NCT00518791Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial
parkinsons · NetherlandsPHASE3
parkinsons · NetherlandsPHASE3
NCT05596201Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's Disease
parkinsons · NetherlandsCOMPLETED
parkinsons · NetherlandsCOMPLETED
NCT00432081Effect of Indomethacin on the Progression of Alzheimer's Disease
alzheimers · NetherlandsPHASE3
alzheimers · NetherlandsPHASE3
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →